NEW DELHI — When the weight loss drug Mounjaro came on the market in India earlier this year, Shyamanthak Kiran was one of the first patients to try …
Drugs
- Sci/Health
Did Medicare price negotiations help Trump’s obesity drugs deals?
by eNewsBlogby eNewsBlogThe Trump administration’s deal on weight loss drugs might have been made possible in part by Biden’s Medicare drug price negotiation program, three experts said. Trump’s deal will …
- Auz/NZ
Man collapses in Oval Office as Trump meets with pharmacy executives | Drugs
by eNewsBlogby eNewsBlogNewsFeed Video shows an attendee collapsing during an Oval Office event on lowering weight-loss drug prices. White House medical staff responded immediately. Press Secretary Karoline Leavitt said the …
- Crypto
Medicare to Cover GLP-1 Drugs for as Little as $50 a Month Under Trump Plan
by eNewsBlogby eNewsBlogKey Takeaways Medicare and Medicaid will cover drugs used for weight loss for the first time, offering Wegovy, Zepbound, Monjauro, and Ozempic for $50 a month co-pays. The …
- Asia
Afghanistan’s opium crop falls 20 percent as synthetic drugs surge | Drugs News
by eNewsBlogby eNewsBlogUN says the area devoted to opium poppies has dropped to a fraction of that cultivated before the Taliban’s narcotics ban in 2022. Afghanistan’s once-booming opium industry has …
- USA
FDA warns websites selling fake or unapproved forms of Botox, similar drugs
by eNewsBlogby eNewsBlogU.S. health regulators sent warning letters Wednesday to 18 websites selling counterfeit or unapproved versions of Botox and similar injectable drugs commonly used to smooth wrinkles. The Food …
IE 11 is not supported. For an optimal experience visit our site on another browser. Missing California hunter found after nearly 3 weeks 01:05 6 deaths tied to …
For years, obesity rates in the US have gone in one direction: up. From the first year it was launched, Gallup’s National Health and Well-Being Index has found …
- Crypto
Gilead posts higher profit on demand for HIV drugs, but overall sales dip
by eNewsBlogby eNewsBlogBy Deena Beasley (Reuters) -Gilead Sciences said on Thursday its HIV drug sales rose 4% to $5.3 billion in the third quarter including $39 million for its new …